Skip Navigation

According to the authors of a recently published article in the New England Journal of Medicine, findings from the Adaptive COVID-19 Treatment Trial, support remdesivir as the standard treatment for patients hospitalized with COVID-19 and requiring supplemental oxygen therapy.

Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery